$BLGO
BIOLARGO, INC.

2016 Q3 Form 10-Q Financial Statement

#000143774916042093 Filed on November 14, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q4 2015 Q3
Revenue $162.3K $50.00K $43.34K
YoY Change 274.57% -16.67% 116.68%
Cost Of Revenue $47.11K $30.00K $19.93K
YoY Change 136.39% -25.0% 99.3%
Gross Profit $115.2K $30.00K $23.41K
YoY Change 392.24% 0.0% 134.05%
Gross Profit Margin 70.98% 60.0% 54.01%
Selling, General & Admin $989.2K $680.0K $1.455M
YoY Change -32.02% 17.24% 123.88%
% of Gross Profit 858.63% 2266.67% 6217.69%
Research & Development $348.6K $220.0K $162.3K
YoY Change 114.85% 37.5% -14.6%
% of Gross Profit 302.6% 733.33% 693.27%
Depreciation & Amortization $3.005K $0.00 $2.730K
YoY Change 10.07%
% of Gross Profit 2.61% 0.0% 11.66%
Operating Expenses $1.341M $890.0K $1.618M
YoY Change -17.1% 18.67% 92.56%
Operating Profit -$1.226M -$860.0K -$1.597M
YoY Change -23.25% 19.44% 92.39%
Interest Expense $1.088M -$430.0K $247.3K
YoY Change 339.76% 975.0%
% of Operating Profit
Other Income/Expense, Net -$1.258M $40.00K $20.00K
YoY Change -6392.33%
Pretax Income -$2.480M -$1.260M -$1.820M
YoY Change 36.26% 65.79% 116.67%
Income Tax
% Of Pretax Income
Net Earnings -$2.484M -$1.250M -$1.823M
YoY Change 36.25% 68.92% 119.67%
Net Earnings / Revenue -1530.36% -2500.0% -4207.34%
Basic Earnings Per Share
Diluted Earnings Per Share -$27.34K -$14.60K -$21.55K
COMMON SHARES
Basic Shares Outstanding 88.15M 84.46M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.730M $1.760M $560.0K
YoY Change 208.93% 1073.33% 273.33%
Cash & Equivalents $1.732M $1.763M $560.2K
Short-Term Investments
Other Short-Term Assets $30.00K $50.00K $60.00K
YoY Change -50.0% 0.0% 20.0%
Inventory $25.62K $37.44K $10.00K
Prepaid Expenses $32.25K $49.17K
Receivables $83.29K $41.43K $40.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.873M $1.891M $670.0K
YoY Change 179.57% 722.24% 157.69%
LONG-TERM ASSETS
Property, Plant & Equipment $55.01K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $39.46K $19.16K $100.0K
YoY Change -60.54% -36.14% 233.33%
Total Long-Term Assets $94.47K $19.16K $100.0K
YoY Change -5.53% -36.14% 150.0%
TOTAL ASSETS
Total Short-Term Assets $1.873M $1.891M $670.0K
Total Long-Term Assets $94.47K $19.16K $100.0K
Total Assets $1.968M $1.910M $770.0K
YoY Change 155.53% 634.73% 156.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $230.0K $174.5K $280.0K
YoY Change -17.86% -43.7% -28.21%
Accrued Expenses $100.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $831.2K $460.0K $400.0K
YoY Change 107.81% -29.23% -35.48%
LONG-TERM LIABILITIES
Long-Term Debt $5.448M $3.246M $110.0K
YoY Change 4852.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.448M $3.246M $110.0K
YoY Change 4852.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $831.2K $460.0K $400.0K
Total Long-Term Liabilities $5.448M $3.246M $110.0K
Total Liabilities $2.128M $768.9K $560.0K
YoY Change 279.94% 8.3% -20.0%
SHAREHOLDERS EQUITY
Retained Earnings -$89.68M -$84.08M
YoY Change
Common Stock $60.11K $57.24K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$760.0K $351.8K $210.0K
YoY Change
Total Liabilities & Shareholders Equity $1.968M $1.910M $770.0K
YoY Change 155.53% 634.73% 156.67%

Cashflow Statement

Concept 2016 Q3 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$2.484M -$1.250M -$1.823M
YoY Change 36.25% 68.92% 119.67%
Depreciation, Depletion And Amortization $3.005K $0.00 $2.730K
YoY Change 10.07%
Cash From Operating Activities -$1.110M -$540.0K -$530.0K
YoY Change 109.43% 80.0% 29.27%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$50.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.010M 1.780M 990.0K
YoY Change 103.03% 493.33% 296.0%
NET CHANGE
Cash From Operating Activities -1.110M -540.0K -530.0K
Cash From Investing Activities -50.00K
Cash From Financing Activities 2.010M 1.780M 990.0K
Net Change In Cash 850.0K 1.240M 460.0K
YoY Change 84.78% -387.5%
FREE CASH FLOW
Cash From Operating Activities -$1.110M -$540.0K -$530.0K
Capital Expenditures -$50.00K
Free Cash Flow -$1.060M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 blgo Accrued Payroll Taxes Possible Reduced Amount
AccruedPayrollTaxesPossibleReducedAmount
5000
blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
9387214
blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
5670996
CY2015Q4 blgo Consulting Services Monthly Payment
ConsultingServicesMonthlyPayment
23438
CY2015Q4 blgo Consulting Services Period Of Services
ConsultingServicesPeriodOfServices
P4Y
CY2015Q4 blgo Discount On Convertible Note Payable Current
DiscountOnConvertibleNotePayableCurrent
CY2016Q3 blgo Discount On Convertible Note Payable Current
DiscountOnConvertibleNotePayableCurrent
78826
CY2015Q4 blgo Discount On Convertible Note Payable Net Of Current Portion
DiscountOnConvertibleNotePayableNetOfCurrentPortion
2937019
CY2016Q3 blgo Discount On Convertible Note Payable Net Of Current Portion
DiscountOnConvertibleNotePayableNetOfCurrentPortion
3871450
CY2016Q3 blgo Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
6
blgo Proceeds From Sale Of Convertible Notes Payable
ProceedsFromSaleOfConvertibleNotesPayable
1768000
blgo Proceeds From Sale Of Convertible Notes Payable
ProceedsFromSaleOfConvertibleNotesPayable
2190000
CY2015 blgo Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
0
CY2016Q3 blgo Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
1150000
CY2016Q3 blgo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
355000
blgo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
355000
blgo Warrants Exercised
WarrantsExercised
1150000
blgo Warrants Expired
WarrantsExpired
4582079
blgo Warrants Expired
WarrantsExpired
263545
CY2016Q3 blgo Working Capital
WorkingCapital
1041864
CY2016Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
290076
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
324983
CY2015Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
174539
CY2016Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
52576
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41431
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83287
CY2016Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
120000
CY2016Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
100000
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
CY2015Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
137500
CY2016Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
137500
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40567
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-62290
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84410821
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
88925035
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
645808
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2460975
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
529920
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1577845
CY2015Q4 us-gaap Assets
Assets
1910304
CY2016Q3 us-gaap Assets
Assets
1967575
CY2016Q3 us-gaap Assets Current
AssetsCurrent
1873107
CY2015Q4 us-gaap Assets Current
AssetsCurrent
1891147
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1731946
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154460
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1763114
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
560171
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
405711
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-31168
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8838122
CY2015Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13643257
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13779438
CY2016Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
18036889
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85648015
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89915980
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
57236
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
60114
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1820854
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8190
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8580
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2426059
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3804596
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5626880
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2398
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-69843
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-13742
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-191674
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1823252
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2495902
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1653711
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5818554
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
105000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
352566
CY2015Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3245972
CY2016Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
5117876
CY2015Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
CY2016Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
280000
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
19930
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
47112
us-gaap Cost Of Revenue
CostOfRevenue
33994
us-gaap Cost Of Revenue
CostOfRevenue
68950
CY2015Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
135000
CY2016Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2730
CY2016Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3005
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8190
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8580
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
CY2016Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
303880
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-21723
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
202110
CY2015Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2016Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
202110
CY2015Q3 us-gaap Gross Profit
GrossProfit
23405
CY2016Q3 us-gaap Gross Profit
GrossProfit
115209
us-gaap Gross Profit
GrossProfit
38827
us-gaap Gross Profit
GrossProfit
146299
us-gaap Income Taxes Paid
IncomeTaxesPaid
4000
us-gaap Income Taxes Paid
IncomeTaxesPaid
6509
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-233965
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62681
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32784
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
41856
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
25000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-135000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
100000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12812
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11815
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
28542
us-gaap Interest Expense
InterestExpense
1972428
CY2016Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
280000
CY2015Q4 us-gaap Liabilities
Liabilities
768936
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10417
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-16913
CY2015Q3 us-gaap Interest Expense
InterestExpense
247310
CY2016Q3 us-gaap Interest Expense
InterestExpense
1087578
us-gaap Interest Expense
InterestExpense
564383
CY2016Q3 us-gaap Liabilities
Liabilities
2127669
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1910304
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1967575
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
459983
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
831243
CY2016Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.18
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3245972
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3804596
CY2015Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
247310
us-gaap Interest Expense Debt
InterestExpenseDebt
564383
CY2016Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1087578
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2799096
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1340139
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2398
CY2016Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-69843
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13742
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-191674
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1820854
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2414260
us-gaap Interest Expense Debt
InterestExpenseDebt
1972428
us-gaap Interest Paid
InterestPaid
13803
us-gaap Interest Paid
InterestPaid
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
12944
CY2016Q3 us-gaap Interest Payable Current
InterestPayableCurrent
36113
CY2015Q4 us-gaap Inventory Net
InventoryNet
37435
CY2016Q3 us-gaap Inventory Net
InventoryNet
25620
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
530737
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
702743
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5447876
CY2015Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
CY2016Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
50000
CY2015Q4 us-gaap Minority Interest
MinorityInterest
789573
CY2016Q3 us-gaap Minority Interest
MinorityInterest
597899
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1745850
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2845000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-55349
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5605157
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1596836
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1225638
us-gaap Operating Income Loss
OperatingIncomeLoss
-3311877
us-gaap Operating Income Loss
OperatingIncomeLoss
-3735612
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19157
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39459
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21723
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11799
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
72320
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
22150
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
55349
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
49167
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
32254
CY2016Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
300000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
300000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
355000
us-gaap Profit Loss
ProfitLoss
-5796831
us-gaap Profit Loss
ProfitLoss
-3818338
CY2015Q3 us-gaap Profit Loss
ProfitLoss
-1823252
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-2484103
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55009
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
162261
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
348619
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
467471
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1029637
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89680852
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84075695
CY2015Q3 us-gaap Revenue From Grants
RevenueFromGrants
20894
CY2016Q3 us-gaap Revenue From Grants
RevenueFromGrants
31223
us-gaap Revenue From Grants
RevenueFromGrants
57922
us-gaap Revenue From Grants
RevenueFromGrants
113319
us-gaap Revenues
Revenues
215249
CY2015Q3 us-gaap Royalty Revenue
RoyaltyRevenue
CY2016Q3 us-gaap Royalty Revenue
RoyaltyRevenue
55000
us-gaap Royalty Revenue
RoyaltyRevenue
us-gaap Royalty Revenue
RoyaltyRevenue
55000
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
43335
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
107321
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
72821
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
160249
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84459614
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88148092
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83616879
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
43335
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
162321
us-gaap Sales Revenue Net
SalesRevenueNet
72821
us-gaap Sales Revenue Net
SalesRevenueNet
215249
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1455250
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
989223
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2875043
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2843694
us-gaap Share Based Compensation
ShareBasedCompensation
1638706
us-gaap Share Based Compensation
ShareBasedCompensation
645808
us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
P5Y
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
352566
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
702743
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1141368
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-160094
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and revenues and expenses during the period reported. Actual results could differ from those estimates. Estimates are used when accounting for stock-based compensation&nbsp;and financing transactions, uncollectible accounts receivable, asset impairment and amortization, and taxes, among others.</div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The methods, estimates and judgments we use in applying these most critical accounting policies have a significant impact on the results of our financial statements. &nbsp;</div></div></div></div></div></div>
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86809862

Files In Submission

Name View Source Status
0001437749-16-042093-index-headers.html Edgar Link pending
0001437749-16-042093-index.html Edgar Link pending
0001437749-16-042093.txt Edgar Link pending
0001437749-16-042093-xbrl.zip Edgar Link pending
blgo-20160930.xml Edgar Link completed
blgo-20160930.xsd Edgar Link pending
blgo-20160930_cal.xml Edgar Link unprocessable
blgo-20160930_def.xml Edgar Link unprocessable
blgo-20160930_lab.xml Edgar Link unprocessable
blgo-20160930_pre.xml Edgar Link unprocessable
blgo20160901_10q.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
ex4-1.htm Edgar Link pending
ex4-2.htm Edgar Link pending
ex4-3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending